California, Hawaii, Oregon and Washington issued COVID-19, influenza, and RSV vaccination guidance in line with former CDC recommendations.
ACIP voted unanimously to recommend that adults aged more than 65 years discuss with an HCP before receiving the COVID-19 vaccines.
Upadacitinib and secukinumab for PsA offers comparable improvements in skin and joint symptoms, but adalimumab offers superior pain relief.
Patients with psoriasis had a significantly increased risk for developing unspecified age-related macular degeneration at 10 years.
A digital psychological intervention was linked to improved psychological outcomes and quality of life in patients with IRDs.
The FDA has expanded the approval of Opzelura to include patients 2 to 11 years of age for treatment of mild to moderate atopic dermatitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback